Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia

Schizophrenia Research

Volumn 32, Issue 2, 1998, Pages 87-92

  Li, Tao ^a,b   Arranz, Maria ^a   Aitchison, Katherine J ^a   Bryant, Catherine ^c   Liu, Xiehe ^b   Kerwin, Robert W ^a   Murray, Robin ^a   Sham, Pak ^a   Collier, David A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SICHUAN UNIVERSITY   (China)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Allelic association; Candidate genes; Catecholamines; Psychosis

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHINESE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RISK ASSESSMENT; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RISK FACTORS; SCHIZOPHRENIA;

EID: 0032572622     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00024-3     Document Type: Article

References (32)

1. American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC.
2. Arinami, T., Itokawa, M., Komiyama, T., Mitsushio, H., Mori, H., Mifune, H., Hamaguchi, H., Toru, M., 1993. Association between alcoholism and the A1 allele of the dopamine D2 receptor gene Taq1 RFLP in Japanese. Biol. Psychiatry 33, 108-114.
3. Arinami, T., Itokawa, M., Enguchi, H., Tagaya, H., Yano, S., Shimizu, H., Hamaguchi, H., Toru, M., 1994. Association of a dopamine D2 molecular variant with schizophrenia. Lancet 343, 703-704.
4. Arinami, T., Itokawa, M., Aoki, J., Shibuya, H., Ookubu, Y., Iwawaki, A., Ota, K., Shimizu, H., Hamaguchi, H., Toru, M., 1996. Further association study of the dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am. J. Med. Genet. 67, 133-138.
5. Arinami, T., Gao, M., Hamaguchi, H., Toru, M., 1997. A functional polymorphism in the promoter region of the dopamine D4 receptor gene is associated with schizophrenia. Hum. Mol. Genet. 6, 577-582.
6. Arranz, M.J., Munro, J., Owen, M.J., Spurlock, G., Sham, P.C., Zhao, J., Kirov, G., Collier, D.A., Kerwin, R.W., 1998. Evidence for association between polymorphisms in the promoter region of the 5-HT2A gene and response to clozapine. Mol. Psychiatry 3, 61-66.
7. Asherson, P., Williams, N., Roberts, E., McGuffin, P., Owen, M., 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia [letter]. Lancet 343, 1045
8. Blum, K., Wood, R.C., Sheridan, P.J., Braverman, E.R., Chen, T.J.H., Coming, D.E., 1995. Dopamine D2 receptor variants: association and linkage studies in impulsive-addictive-compulsive disorders. Pharmacogenetics 5, 121-124.
9. Blum, K., Braverman, E.R., Wu, S., Cull, J.G., Chen, T.J.H. et al., 1997. Association of polymorphisms of dopamine D2 receptor (DRD2) and dopamine transporter (DAT1 ) genes with schizoid/avoidant behaviours. Mol. Psychiatry 2, 239-246.
10. Bolos, A.M., Dean, M., Lucas-Derse, S., Ramsberg, M., Brown, G.L., Goldman, D., 1990. Population and pedigree studies reveal a lack of association between the dopamine D2 gene and alcoholism. J. Am. Med. Assoc. 264, 3156-3160.
11. Cloninger, C.R., 1991. D2 dopamine receptor gene is associated with but not linked to alcoholism. J. Am. Med. Assoc. 266, 1833-1844.
12. Cook, C.C.H., Brett, P., Curtis, D., Holmes, D., Gurling, H.M.D., 1993. Linkage analysis confirms a genetic effect at the dopamine D2 receptor in heavy drinking and alcoholism. Psychiatr. Genet. 3, 130
13. Creese, I., Burt, D.R., Snyder, S.H., 1976. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483.
14. Eden, R.J., Costall, B., Domeney, A.M., Gerrard, P.A., Harvey, C.A., Kelly, M.E., Naylor, R.J., Owen, D.A., Wright, A., 1991. Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacol. Biochem. Behav. 38, 147-154.
15. Falk, C.T., Rubenstein, P., 1987. Haplotype relative risks: an easy way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227-233.
16. Gelertner, J., O'Malley, S.O., Risch, N., Kranzler, R.R., Krystal, J., Merikangas, K., Kennedy, J.L., Kidd, K.K., 1991. No association between an allele at the D2 receptor gene and alcoholism. J. Am. Med. Assoc. 47, 1073-1077.
17. Karyiorgou, M., Gogos, J.A., 1997. Dissecting the genetic complexity of schizophrenia. Mol. Psychiatry 2, 211-223.
18. Laurent, C., Bodeau-Pean, S., Campion, D., d'Amato, T., Jay, M., Dollfus, S., Thibault, F., Petit, M., Samolyk, D., Martinez, M. et al., 1994. No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr. Genet. 4, 229-230.
19. McGuffin, P., Owen, M.J., Farmer, A.E., 1995. Genetic basis of schizophrenia. Lancet 346, 678-682.
20. Nanko, S., Hattori, M., Dai, X.Y., Fukuda, R., Kazamatsuri, H., 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia [letter]. Lancet 343, 1044
21. Nothen, M.M., Wildenauer, D., Cichon, S., Albus, M., Maier, W., Minges, J., Lichtermann, D., Bondy, B., Rietschel, M., Korner, J. et al., 1994. Dopamine D2 receptor molecular variant and schizophrenia [letter]. Lancet 343, 1301-1302.
22. Pato, C.N., Macciardi, F., Pato, M.T., Verga, M., Kennedy, J.L., 1993. Review of the putative association of the dopamine D2 receptor and alcoholism: a meta analysis. Am. J. Med. Genet. 48, 78-82.
23. Price-Evans, D.A., 1993. Genetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics. Cambridge University Press, Cambridge.
24. Risch, N., Merikangas, K., 1996. The future of genetic studies of complex human diseases. Science 273, 1516-1517.
25. Sasaki, T., Macciardi, F.M., Badri, F., Verga, M., Meltzer, H.Y., Lieberman, J., Howard, A., Bean, G., Joffe, R.T., Hudson, C.J., Kennedy, J.L., 1996. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. Am. J. Med. Genet. 67, 415-417.
26. Seeman, P., Lee, T., Chau-Wong, M., Wong, K., 1976. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717-719.
27. Shaikh, S., Collier, D., Arranz, M., Ball, D., Gill, M., Kerwin, R., 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia [letter]. Lancet 343, 1045-1046.
28. Shaikh, S., Collier, D.A., Sham, P.C., Ball, D.M., Aitchison, K.J.A., Vallada, H.P., Smith, I., Gill, M., Kerwin, R., 1996. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum. Genet. 97, 714-719.
29. Sham, P., Curtis, D., 1995. An extended transmission/disequilibrium test (TDT) for multiallele marker loci. Ann. Hum. Genet. 59, 323-336.
30. Spielman, R.S., McGinnis, R.E., Ewens, R.J., 1993. Transmission test for linkage disequilibrium: the insulin gene region and IDDM. Am. J. Hum. Genet. 52, 506-516.
31. Steen, V.M., Lovlie, R., MacEwan, T., McReadie, R.G., 1997. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol. Psychiatry 2, 139-145.
32. Terwilliger, J., Ott, J., 1992. A haplotype-based haplotype relative risk approach to detecting allelic associations. Hum. Hered. 42, 337-346.